51¶ÌÊÓƵ

Join us for an illuminating evening exploring the historical advancements that have shaped medical genetics and antibody therapeutics. This event will delve into key milestones, from the foundational techniques in human genetics to the scientific breakthroughs that enabled antibody engineering.

Attendees will gain insight into the origins and progression of serum therapy, its crucial role in treating diseases during the First World War, and its eventual replacement by antibiotics and vaccines. The session will also highlight how improved understanding of disease mechanisms and innovations in technology have driven the development of antibody-based treatments for conditions like viral infections, cancer, autoimmune diseases, and rare disorders.

The program includes the prestigious Annual Bynum Lecture, along with a panel discussion on the legacy and future potential of antibody therapeutics. Attendees will leave with a deeper appreciation of the scientific and medical endeavours that continue to influence modern clinical practices.

By attending, you will:

• Gain a historical understanding of techniques and practices in human genetics
• Develop an appreciation of how genetics became a dominant theme in clinical science
• Gain an appreciation of the developments that led to antibody engineering
• 51¶ÌÊÓƵ about the discovery of diphtheria and tetanus antitoxins, the development of serum therapy, its benefits and disadvantages, applications in the First World War, displacement by antibiotics and vaccines, and use of serum from convalescent patients.
• Understand how technical innovations, coupled with an improved understanding of disease mechanisms, enabled the development of new antibody therapeutics for viral infections, cancer, autoimmune diseases, allergy and rare disorders. 
• Develop an appreciation of the characteristics of biomedical innovation common across multiple generations of antibody-based treatments driven by medical need and scientific endeavour.

Follow us on:Ìý
Ìý
Ìý
Ìý
Ìý
Ìý